Aarti Pharmalabs Chairman Chandrakant Vallabhaji Gogri passes away
Aarti Pharmalabs (AARTIPHARM) said Chandrakant Vallabhaji Gogri, Chairman, has passed away. The company is valued at about ₹9,049 crore.
What happened
In a filing with the BSE on 15 November 2026 at 11:13 PM, Aarti Pharmalabs (AARTIPHARM) said that Chandrakant Vallabhaji Gogri, Chairman, has passed away.
From the filing: "the Company Dear Sir/Madam, With profound grief, we inform you of the demise of Shri Chandrakant Vallabhaji Gogri, Chairman Emeritus and Promoter of the Company, today, i.e., Sunday, November 15, 2026."
Company snapshot
Aarti Pharmalabs is a small-cap company in the Healthcare sector, with a market value of about ₹9,049 crore.
The stock last traded at ₹998, against a 52-week range of ₹585–₹1,019.5 (2.1% below the high).
Before this filing the shares had moved +15.0% over the month and +17.2% over three months. Average daily turnover over the last 20 sessions was about ₹62.2 crore.
Promoters held 39.66% at the end of Q2 FY27, down 3.20% points from the previous quarter; 11.98% of promoter shares were pledged. Foreign institutions owned 8.15% and domestic institutions 8.40%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 418 | 28.6 | 3.08 |
| Q3 FY26 | 432 | 46.4 | 5.29 |
| Q4 FY26 | 583 | 61.1 | 6.74 |
| Q1 FY27 | 536 | 76.1 | 8.4 |
| Q2 FY27 | 610 | 68.9 | 7.88 |
What history shows
BCEIE's records show 9 previous management change filings from the company since May 2026.
After those filings, the stock gained 6.1% on average the next trading day and was up 8.4% on average after five days (7 filings with price data).
Across 137 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +1.7% over five days; 52% of them rose the next day.
Market-wide, 4,563 management change filings with an impact score of 50 or more saw an average next-day move of −0.0%, with 46% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 28 Oct 2026 | Resignation of Director/KMP/SMP | −1.0% | +5.3% |
| 28 Oct 2026 | Resignation of Shri Piyush Lakhani as Chief Financial Officer of the… | −1.0% | +5.3% |
| 28 Oct 2026 | Management change | −1.0% | +5.3% |
| 28 Oct 2026 | Management change | −1.0% | +5.3% |
| 7 Aug 2026 | Change in Director(s) of the company. | +28.8% | +25.7% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- Aarti Pharmalabs Share Price - Live NSE: AARTIPHARM Stock Price & Chart
- Aarti Pharmalabs Limited: 10-12 projects drive Rs 800 crore CDMO
- Aarti Pharmalabs targets 8,800 tonnes, pauses xanthine expansion
- Diwali Muhurat Trading 2026: Angel One’s 8 Stock Picks For Samvat 2083, ICICI Bank, Aarti Pharmalabs Among Top Bets
- Aarti Pharmalabs Q2 FY27 Earnings Call Key Highlights
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.